[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370445-105":59,"doc-detail-370445-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrating-bioinformatics-with-experimental-validation-unveils-immunological-and-prognostic-significance-of-pvrig-in-pan-cancer","Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer","","Integrating bioinformatics with experimental validation to clarify the immunological and prognostic relevance of PVRIG across cancers. PVRIG is described as a recently identified immune checkpoint receptor mainly expressed on natural killer and CD8+ T cells, and its expression is linked to immune infiltration, immune modulator gene programs, clinical outcomes, CD8+ T-cell functionality, and sensitivity to immunotherapies and targeted treatments. Bioinformatics findings are supported by in vitro and in vivo experiments showing PVRIG’s critical control of CD8+ T-cell functional regulation, positioning PVRIG as a biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-bioinformatics-with-experimental-validation-unveils-immunological-and-prognostic-significance-of-pvrig-in-pan-cancer/370445/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-bioinformatics-with-experimental-validation-unveils-immunological-and-prognostic-significance-of-pvrig-in-pan-cancer/370445.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PVRIG and why is it important in cancer immunology?","Question",{"text":112,"@type":113},"PVRIG is a newly identified immune checkpoint receptor expressed mainly on NK and CD8+ T cells. The document emphasizes its role in regulating the tumor immune microenvironment and influencing clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was PVRIG investigated in this pan-cancer study?",{"text":117,"@type":113},"The study used TCGA pan-cancer atlas data for expression and prognostic correlations, added single-cell sequencing to examine PVRIG in tumor-infiltrating lymphocytes, and performed in vitro and in vivo experiments to test its effects on CD8+ T-cell functionality.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports PVRIG’s role in CD8+ T-cell function?",{"text":121,"@type":113},"In vitro and in vivo experiments confirmed that PVRIG critically regulates CD8+ T-cell functionality, linking receptor biology to immune performance in the tumor context.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370445,1790217766,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer  \nPeng Ma1, Ruichen Zhang2 & Weili Sun3,4􀀍  \nThe poliovirus receptor-related immunoglobulin domain-containing protein (PVRIG) is a recently identified immune checkpoint receptor predominantly expressed on natural killer and CD8 +T cells. This study investigated the role of PVRIG in the tumor immune microenvironment and its prognostic significance across various cancers. Using bioinformatics analyses, the study revealed that PVRIG expression is associated with immune cell infiltration, immune modulator gene expression, clinical outcomes, CD8 +T cell functionality, and responses to immunotherapies and targeted treatments. Additionally, in vitro and in vivo experiments confirmed that PVRIG plays a critical role in regulating CD8 +T cell functionality. These findings suggest that PVRIG could serve as a biomarker for prognosis and immune infiltration, as well as a promising target for novel cancer immunotherapies.  \nKeywords PVRIG, Prognosis, Immune checkpoint, Cancer, Immunotherapy  \nIn 2022, approximately 20 million people worldwide were diagnosed with cancer, resulting in about 9.7 million cancer-related deaths. Projections suggest that the global cancer burden will surpass 35 million cases by 20501,2. Despite advancements in standard treatment modalities such as chemotherapy, radiotherapy, and surgery, outcomes remain suboptimal, with high recurrence rates and limited survival benefits for advanced-stage cancers. However, the development of new immune checkpoint-based immunotherapies, such as cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death protein-1 (PD-1) inhibitors, has shown promising results across various cancers3. Yet, these therapies are highly specific, relying on the presence of particular receptors on the plasma membranes of cancer cells. Consequently, only around 30% of cancer patients respond positively to these therapies4. Hence, there is a pressing need to identify additional checkpoint receptors to enhance patient responses to immunotherapy.  \nThe poliovirus receptor (PVR) serves as a pivotal regulator of the cell-mediated immune response. The poliovirus receptor-related immunoglobulin domain-containing protein (PVRIG), also known as CD112R, is an emerging member of the CD226 (DNAM-1) axis and has recently been identified as a novel inhibitory receptor for PVR (CD112)5,6. PVRIG competes with CD226 for PVR binding, exhibiting a stronger affinity for PVR than CD226, which induces activating signals in T and natural killer (NK) cells7–11. Similar to CD96 and TIGIT co-inhibitory receptors, PVRIG’s intracellular domain contains an ITIM-like motif, which is believed to mediate intrinsic inhibitory signaling6,7, 12. PVRIG has been identified on the plasma membranes of various T and NK cell subtypes, with upregulation observed in antigen-specific activated CD8 + T cells6,7, 13. Increased PVRIG expression has been noted on tumor-infiltrating lymphocytes (TILs), such as tumor-infiltrating NK cells, across several cancer types, including lung, breast, endometrial, kidney, and ovarian cancers12, 14. Furthermore, elevated PVRIG expression has been detected on exhausted T cells from human cancers and antigen-specific exhausted CD8 + T cells from virus-infected mice, suggesting a role for PVRIG in facilitating the transition ofT cells from activation to exhaustion7, 13, 14. Previous studies have demonstrated that PVRIG blockade can impede tumor growth by enhancing the antitumor activities of NK and T cells, particularly when coupled with PD-L1 blockade4, 13, 15. PVRIG-deficient tumor-infiltrating NK cells and CD8 + T cells produce more pro-inflammatory cytokines, underscoring the significant role of PVRIG in modulating NK and T cell functions within tumors4,7, 13.  \n1Department of Gastroenter","cbCaijdBc7VUyODq","https://ap.wps.com/l/cbCaijdBc7VUyODq","pdf",6837801,18,"English","# Background\n## Rationale for additional checkpoint receptors\n# PVRIG biology and immune regulation\n## Relationship with CD226 axis and ITIM-like motif\n## Expression patterns in cancers\n# Study design and analyses\n## TCGA pan-cancer data and immune profiling\n## Single-cell sequencing and CD8+ T-cell experiments\n## GSEA and therapeutic response evaluation\n# Key findings and implications","[{\"question\":\"What is PVRIG and why is it important in cancer immunology?\",\"answer\":\"PVRIG is a newly identified immune checkpoint receptor expressed mainly on NK and CD8+ T cells. The document emphasizes its role in regulating the tumor immune microenvironment and influencing clinical outcomes.\"},{\"question\":\"How was PVRIG investigated in this pan-cancer study?\",\"answer\":\"The study used TCGA pan-cancer atlas data for expression and prognostic correlations, added single-cell sequencing to examine PVRIG in tumor-infiltrating lymphocytes, and performed in vitro and in vivo experiments to test its effects on CD8+ T-cell functionality.\"},{\"question\":\"What experimental evidence supports PVRIG’s role in CD8+ T-cell function?\",\"answer\":\"In vitro and in vivo experiments confirmed that PVRIG critically regulates CD8+ T-cell functionality, linking receptor biology to immune performance in the tumor context.\"}]","Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer | PDF",1790188532,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d703dbe97b860867ed672376b2738bfa.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8463402a5c2feb3f5fa6c1546e1c4c2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43726f9141e9da0206e07b5d8b9e2660.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07d2991acc8406c13e53854082c649fa.webp",980,1287]